<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="brief-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Epigenetics</journal-id>
<journal-id journal-id-type="iso-abbrev">Epigenetics</journal-id>
<journal-id journal-id-type="publisher-id">KEPI</journal-id>
<journal-id journal-id-type="publisher-id">kepi20</journal-id>
<journal-title-group>
<journal-title>Epigenetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1559-2294</issn>
<issn pub-type="epub">1559-2308</issn>
<publisher>
<publisher-name>Taylor &amp; Francis</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29412786</article-id>
<article-id pub-id-type="pmc">5810764</article-id>
<article-id pub-id-type="publisher-id">1391429</article-id>
<article-id pub-id-type="doi">10.1080/15592294.2017.1391429</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>MeCP2 interacts with chromosomal microRNAs in brain</article-title>
<alt-title alt-title-type="running-authors">A. W. KHAN ET AL.</alt-title>
<alt-title alt-title-type="running-title">EPIGENETICS</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Khan</surname>
<given-names>Abdul Waheed</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="af0003">
<sup>c</sup>
</xref>
<xref ref-type="author-notes" rid="afn0001">
<sup>*</sup>
</xref>
<xref rid="b0001"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ziemann</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rafehi</surname>
<given-names>Haloom</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maxwell</surname>
<given-names>Scott</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ciccotosto</surname>
<given-names>Giuseppe D.</given-names>
</name>
<xref ref-type="aff" rid="af0003">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="af0004">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>El-Osta</surname>
<given-names>Assam</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="af0002">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="af0003">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="af0005">
<sup>e</sup>
</xref>
<xref ref-type="corresp" rid="an0001"></xref>
<xref rid="b0001"></xref>
</contrib>
<aff id="af0001"><label>a</label><institution>Central Clinical School, Faculty of Medicine, Monash University</institution>, Victoria, <country>Australia</country></aff>
<aff id="af0002"><label>b</label><institution>Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct</institution>, Melbourne, Victoria 3004, <country>Australia</country></aff>
<aff id="af0003"><label>c</label><institution>Department of Pathology, The University of Melbourne</institution>, Parkville, Victoria, <country>Australia</country></aff>
<aff id="af0004"><label>d</label><institution>Bio21 Molecular science and Biotechnology Institute</institution>, Victoria, <country>Australia</country></aff>
<aff id="af0005"><label>e</label><institution>Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, The Chinese University of Hong Kong</institution>, <country>Hong Kong SAR</country></aff>
</contrib-group>
<author-notes>
<corresp id="an0001">Assam El-Osta <email>sam.el-osta@monash.edu</email></corresp>
<fn id="afn0001">
<label>*</label>
<p>Current address: Molecular Cardiology Department of Medicine Karolinska University hospital, Stockholm, Sweden</p>
</fn>
<fn>
<p>Color versions of one or more of the figures in this article can be found online at <ext-link ext-link-type="uri" xlink:href="http://www.tandfonline.com/khvi">www.tandfonline.com/khvi</ext-link>.</p>
</fn>
<fn>
<p>Supplemental data for this article can be accessed at <ext-link ext-link-type="uri" xlink:href="http://htttp://dx.doi.org/10.1080/15592294.2017.1391429">htttp://dx.doi.org/10.1080/15592294.2017.1391429</ext-link></p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>7</day>
<month>2</month>
<year>2018</year>
</pub-date>
<volume>12</volume>
<issue>12</issue>
<fpage seq="2">1028</fpage>
<lpage>1037</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Â© 2018 Taylor &amp; Francis Group, LLC</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Taylor &amp; Francis Group, LLC</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="kepi-12-12-1391429.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Although methyl CpG binding domain protein-2 (MeCP2) is commonly understood to function as a silencing factor at methylated DNA sequences, recent studies also show that MeCP2 can bind unmethylated sequences and coordinate gene activation. MeCP2 displays broad binding patterns throughout the genome, with high expression levels similar to histone H1 in neurons. Despite its significant presence in the brain, only subtle gene expression changes occur in the absence of MeCP2. This may reflect a more complex regulatory mechanism of MeCP2 to complement chromatin binding. Using an RNA immunoprecipitation of native chromatin technique, we identify MeCP2 interacting microRNAs in mouse primary cortical neurons. In addition, comparison with mRNA sequencing data from <italic>Mecp2</italic>-null mice suggests that differentially expressed genes may indeed be targeted by MeCP2-interacting microRNAs. These findings highlight the MeCP2 interaction with microRNAs that may modulate its binding with chromatin and regulate gene expression.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>KEYWORDS</title>
<kwd>MeCP2</kwd>
<kwd>microRNAs</kwd>
<kwd>RNA-chromatin immunoprecipitation</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<named-content content-type="funder-name">National Health and Medical Research Council (NHMRC)</named-content>
<named-content content-type="funder-identifier">10.13039/501100000925</named-content>
</funding-source>
<award-id>APP0526681, APP1113188</award-id>
</award-group>
<funding-statement>This study was supported by a National Health and Medical Research Council (NHMRC) program grants (Numbers APP0526681, APP1113188). We acknowledge the fellowship support from the NHMRC. This work was supported in part by the Victorian Government's Operational Infrastructure Support Program.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="1"></table-count>
<ref-count count="44"></ref-count>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>